Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2006-02-16
2011-11-08
Huff, Sheela J (Department: 1643)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S387100, C530S388100, C530S388800, C530S388850
Reexamination Certificate
active
08053563
ABSTRACT:
The present invention relates to monoclonal anti-human YKL-antibodies which are capable to modulate biological processes in which YKL-40 plays a prominent role, e.g. inhibit the growth and/or inducing apoptosis of cells, in particular cancer cells. The invention also relates to pharmaceutical compositions comprising said antibodies and uses said antibodies and/or pharmaceutical compositions for treatment of a disease wherein inhibition of cell growth, cell differentiation, remodelling of extracellular matrix, metastasis and/or induction of cell death due to apoptosis is a prerequisite for successful curing. An antibody of the invention is capable of inhibiting biological function of YKL-40 in the above mentioned processes by binding to a specific epitope on YKL-40.
REFERENCES:
patent: 5935798 (1999-08-01), Price et al.
patent: 6184204 (2001-02-01), Boots et al.
patent: 7230086 (2007-06-01), Price et al.
patent: 2005/0214297 (2005-09-01), Mao et al.
patent: WO-95/01995 (1995-01-01), None
patent: WO-97/40068 (1997-10-01), None
patent: 00/19206 (2000-04-01), None
patent: WO-00/19206 (2000-04-01), None
Campbell et al Monoclonal Antibody Technology. ed Elseiver p. 1-32 (1984).
Fusetti Von Moeller, et al., J. bIOL cHEM, 277:25537-44, 2002.
Johansen, J.S., et al., Arthritis Rheum, 44: 826-837, 2001.
Recklies, A.D., et al., Biochem, J. (2002) 365, 119-126.
Baeten, D. et al., Arthritis Rheum, 43: 1233-1243, 2000.
Boot R.G., et al., Arterioscler Thromb Vasc Biol, 19: 687-694, 1999.
XP-002382648, Abstract “Chitinase-3-like protein 1 precursor” (1993) 4 pages.
Jooten, L.A.B., et al., Arthritis & Rheumatism, vol. 43, No. 3, Mar. 2000, pp. 645-655.
Cintin C. et al., Cancer, 95: 267-274, 2002.
Coulson A.F. et al., FEBS Lett, 354:41-4, 1994.
Dasuri, K., Arthritis Res Ther, 6:R161-8,2004.
De Ceunick F., et al., Biochem Biophys Res Commun, 285: 926-931, 2001.
Dehn, H., et al., Acta Obstet Gynaecol Scand, 82: 287-293, 2003.
Dupont J., et al., J Clin Oncol, 22:3330-9, 2004.
Ling, Hua and Recklies, A.D., Biochem, J., (2004) 380, 651-659.
Cintin C., et al., Brit J Cancer, 79:1494-1499, 1999.
Geertsen P., et al., Meeting Proceedings of ASCO 2003:22: abstract 1603.
Gregoire M., et al., Cancer Met Rev, 14: 339-350, 1995.
Harvey S., et al., Clin Chem, 44: 509-516, 1998.
Houston, D.R., et al., J Biol Chem. 278: 30206-30212, 2003.
Huang Y. et al., Proc Natl Acad Sci USA, 98: 15044-15049, 2001.
Hogdall E.V.S. et al., Oncol Rep, 10: 1535-1538, 2003.
Imabayashi H., et al., Exp Cell Res, 288: 35-50, 2003.
Jensen B.V., et al., Clin Cancer Res, 9: 4423-4434, 2003.
Johansen, J.S., et al., J Bone Miner Res, 7: 501-512, 1992.
Johansen, J.S., et al., Br J. Rheumatol, 32: 949-955, 1993.
Johansen, J.S., et al., Eur J. Cancer, 31A: 1437-1442, 1995.
Johansen, J.S., et al., Scand J. Gastroenterol, 32: 1997 pp. 587-590.
Johansen, J.S., et al., Rheumatology, 38: 618-626, 1999b.
Johansen, J.S., et al., Arthritis Rheum, 42: 2624-2630, 1999a.
Brasso K. et al., Meeting proceedings of ASCO 2003; 22: abstract 1525.
Fusetti F. et al., J Biol Chem, 278: 37753-37760, 2003.
Johansen, J.S., et al., Breast Cancer Res Treat, 80: 15-21, 2003.
Johansen, J.S. et al., Lung Cancer, 46: 333-40, 2004.
Junker, N. et al., Cancer Science 96:183 (2005).
Junker, N. et al., Lung Cancer 48: 223 (2005).
Kirkpatrick, R.B., et al., Gene, 153: 147-54, 1995.
Kirkpatrick, R.B., et al., Exp Cell Res, 237: 46-54, 1997.
Koutroubakis, I.E. et al., Int J Colorectal Dis, 18: 287-293, 2003.
Kronborg, G., et al., Scand J Infect Dis, 34: 323-326, 2002.
Malinda, K.M. et al., Exp Cell Res, 250: 168-173, 1999.
Mohanty, A.K., et al., J Biol Chem, 278: 14451-14460, 2003.
Morrison, B.W., et al., Oncogene, 9: 3417-3426, 1994.
Nordenbaek, C., et al., J Infect Dis, 180: 1722-1726, 1999.
Nishikawa K.C., et al., Exp Cell Res, 287: 79-87, 2003.
Nyirkos P., et al., Biochem J, 269: 265-8, 1990.
Nojgaard C., et al., J Hepatol, 39: 179-186, 2003.
Recklies, A.D., et al., Biochem J, 365: 119-126, 2002.
Rehli M., et al., Genomics, 43: 221-225, 1997.
Rehil M., et al., J Biol Chem, 278: 44058-44068, 2003.
Renkema, G.H., et al., Eur J. Biochem, 251: 504-509, 1998.
Shackel, N.A., et al., Hepatology, 38: 577-88, 2003.
Shackelton, L.M., et al., J Biol Chem, 270; 13076-83, 1995.
Sjogren, H., et al., Am J Pathol, 162: 781-792, 2003.
Sun, Y.J., et al., J Biol Chem 276: 17507-14, 2001.
Tanwar, M.K., et al., Cancer Res, 62: 4364-4368, 2002.
Tran A., et al., Eur J Gastroenterol Hepatol, 12: 989-993, 2000.
Varela P.F., et al., J Biol Chem 277: 13229-36, 2002.
Verhoeckx, K.C., et al., Proteomics, 4: 1014-28, 2004.
Volck, B., et al., Osteoartritis Cartilage, 9: 203-214, 2001.
Volck, B., et al., Proc Assoc Am Phys, 110: 351-360, 1998.
Johansen, J.S., et al., J Hepatol, 32: 911-920, 2000.
Bonnichsen Richard
Price Paul
BIO-Y A/S
Gifford Krass Sprinkle Anderson & Citkowski P.C.
Huff Sheela J
LandOfFree
YKL-40 monoclonal authority does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with YKL-40 monoclonal authority, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and YKL-40 monoclonal authority will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4271164